While immune-based therapies hold great theoretical promise, practical treatments have not realized their potential due to an inability to understand the immune basis of immune control of HIV replication, the role CD8+ T cells play, the importance of the many effector functions, and the intrinsic difficulties with formulating and evaluating vaccines against HIV/AIDS. The gene discussed is CD8A; the disease is AIDS.